DA4 Buprenorphine and Buprenorphine Naloxone combination Suboxone prescribing guidance
Medical Officers and Substance Misuse Practitioners within drug treatment services and general practices involved in shared care of problem drug users.
To ensure flexible, safe and consistent prescribing practice across drug treatment services.
Lead Clinical Director
Author and contact number
Clinical Directors, D&A Services
0151 604 7309
Policy dates & history
16 October 2012
31 October 2017
Medicines Management Group (MMG)
Document Quality Group (DQG)